IL109237A - Polycyclic compounds and pharmaceutical compositions containing them - Google Patents
Polycyclic compounds and pharmaceutical compositions containing themInfo
- Publication number
- IL109237A IL109237A IL109237A IL10923794A IL109237A IL 109237 A IL109237 A IL 109237A IL 109237 A IL109237 A IL 109237A IL 10923794 A IL10923794 A IL 10923794A IL 109237 A IL109237 A IL 109237A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- compound
- fluoro
- pyridinyl
- bis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4401293A | 1993-04-08 | 1993-04-08 | |
| US08/216,881 US5594001A (en) | 1993-04-08 | 1994-03-28 | Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL109237A0 IL109237A0 (en) | 1994-07-31 |
| IL109237A true IL109237A (en) | 1998-02-08 |
Family
ID=26721086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL109237A IL109237A (en) | 1993-04-08 | 1994-04-06 | Polycyclic compounds and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5990132A (lv) |
| EP (1) | EP0693069A1 (lv) |
| JP (1) | JPH08509713A (lv) |
| CN (2) | CN1058495C (lv) |
| AU (1) | AU690906B2 (lv) |
| BR (1) | BR9405954A (lv) |
| CA (1) | CA2160112A1 (lv) |
| CZ (1) | CZ251995A3 (lv) |
| FI (1) | FI954775A (lv) |
| HU (1) | HUT74104A (lv) |
| IL (1) | IL109237A (lv) |
| LV (1) | LV11179B (lv) |
| NO (1) | NO308745B1 (lv) |
| NZ (1) | NZ265183A (lv) |
| OA (1) | OA10235A (lv) |
| PL (1) | PL178570B1 (lv) |
| RO (1) | RO115162B1 (lv) |
| RU (1) | RU2152944C1 (lv) |
| SI (1) | SI9420022A (lv) |
| SK (1) | SK124695A3 (lv) |
| WO (1) | WO1994024131A1 (lv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750528A (en) * | 1995-02-01 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease |
| US6262081B1 (en) * | 1998-07-10 | 2001-07-17 | Dupont Pharmaceuticals Company | Composition for and method of treating neurological disorders |
| JP5581607B2 (ja) | 2008-06-05 | 2014-09-03 | 住友化学株式会社 | 高分子化合物及びそれを用いた有機トランジスタ |
| PT2909204T (pt) | 2012-10-12 | 2019-03-21 | Dana Farber Cancer Inst Inc | Inibidores de gsk3 e métodos de utilização dos mesmos |
| US20150311450A1 (en) * | 2012-11-30 | 2015-10-29 | Lg Chem, Ltd. | New compounds and organic electronic device using the same |
| WO2015027015A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imidazole-derived modulators of the glucocorticoid receptor |
| WO2015027021A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| CN109820853B (zh) | 2014-02-05 | 2022-05-10 | Vm肿瘤药物有限责任公司 | 取代的杂环化合物在制备治疗癌症药物中的用途 |
| GB201417369D0 (en) * | 2014-10-01 | 2014-11-12 | Redx Pharma Ltd | Compounds |
| US10927126B2 (en) * | 2016-11-07 | 2021-02-23 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| CA3058198A1 (en) | 2017-04-05 | 2018-10-11 | The Broad Institute, Inc. | Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1052346A (lv) * | 1964-09-09 | |||
| US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
| US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
| CA2108889A1 (en) * | 1991-05-29 | 1992-11-30 | Robert Lee Dow | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| DE69218795T2 (de) * | 1992-01-16 | 1997-07-10 | Du Pont Merck Pharma | Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen |
| RU2051151C1 (ru) * | 1992-01-16 | 1995-12-27 | Дзе Дюпон Мерк Фармасьютикал Компани | Азотсодержащие гетероциклические производные флуорена |
| US5272269A (en) * | 1992-01-16 | 1993-12-21 | The Du Pont Merck Pharmaceutical Company | Disubstituted polycyclic systems and preparative methods therefor |
| US5185447A (en) * | 1992-01-29 | 1993-02-09 | Du Pont Merck Pharmaceutical Company | Polycyclic ketones and preparative methods therefor |
| US5359070A (en) * | 1993-02-11 | 1994-10-25 | The Du Pont Merck Pharmaceutical Company | Unsymmetrical bis-imides as anticancer agents |
-
1994
- 1994-04-04 CN CN94191713A patent/CN1058495C/zh not_active Expired - Fee Related
- 1994-04-04 CZ CZ952519A patent/CZ251995A3/cs unknown
- 1994-04-04 RO RO95-01753A patent/RO115162B1/ro unknown
- 1994-04-04 SI SI9420022A patent/SI9420022A/sl unknown
- 1994-04-04 BR BR9405954A patent/BR9405954A/pt not_active Application Discontinuation
- 1994-04-04 AU AU65549/94A patent/AU690906B2/en not_active Ceased
- 1994-04-04 RU RU95120594/04A patent/RU2152944C1/ru active
- 1994-04-04 JP JP6523257A patent/JPH08509713A/ja active Pending
- 1994-04-04 PL PL94310997A patent/PL178570B1/pl unknown
- 1994-04-04 EP EP94913355A patent/EP0693069A1/en not_active Withdrawn
- 1994-04-04 HU HU9502929A patent/HUT74104A/hu unknown
- 1994-04-04 CA CA002160112A patent/CA2160112A1/en not_active Abandoned
- 1994-04-04 NZ NZ265183A patent/NZ265183A/en unknown
- 1994-04-04 SK SK1246-95A patent/SK124695A3/sk unknown
- 1994-04-04 WO PCT/US1994/003673 patent/WO1994024131A1/en not_active Application Discontinuation
- 1994-04-06 IL IL109237A patent/IL109237A/en not_active IP Right Cessation
-
1995
- 1995-10-06 FI FI954775A patent/FI954775A/fi unknown
- 1995-10-06 NO NO953989A patent/NO308745B1/no not_active IP Right Cessation
- 1995-10-06 OA OA60720A patent/OA10235A/en unknown
- 1995-10-09 LV LVP-95-302A patent/LV11179B/en unknown
-
1996
- 1996-06-17 US US08/664,631 patent/US5990132A/en not_active Expired - Fee Related
-
2000
- 2000-01-08 CN CN00100940A patent/CN1295072A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RO115162B1 (ro) | 1999-11-30 |
| FI954775A0 (fi) | 1995-10-06 |
| CZ251995A3 (en) | 1996-01-17 |
| IL109237A0 (en) | 1994-07-31 |
| NO953989L (no) | 1995-12-07 |
| NO308745B1 (no) | 2000-10-23 |
| PL310997A1 (en) | 1996-01-22 |
| FI954775A (fi) | 1995-10-06 |
| SI9420022A (en) | 1996-10-31 |
| HU9502929D0 (en) | 1995-11-28 |
| NZ265183A (en) | 1997-11-24 |
| BR9405954A (pt) | 1995-12-26 |
| WO1994024131A1 (en) | 1994-10-27 |
| AU6554994A (en) | 1994-11-08 |
| JPH08509713A (ja) | 1996-10-15 |
| RU2152944C1 (ru) | 2000-07-20 |
| CN1295072A (zh) | 2001-05-16 |
| HUT74104A (en) | 1996-11-28 |
| EP0693069A1 (en) | 1996-01-24 |
| NO953989D0 (no) | 1995-10-06 |
| OA10235A (en) | 1997-10-07 |
| CA2160112A1 (en) | 1994-10-27 |
| CN1058495C (zh) | 2000-11-15 |
| PL178570B1 (pl) | 2000-05-31 |
| LV11179B (en) | 1997-06-20 |
| SK124695A3 (en) | 1996-06-05 |
| LV11179A (lv) | 1996-04-20 |
| CN1122135A (zh) | 1996-05-08 |
| US5990132A (en) | 1999-11-23 |
| AU690906B2 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI647228B (zh) | 新穎之經(雜)芳基取代之哌啶基衍生物、其製備方法及含其之醫藥組合物 | |
| US9458155B2 (en) | Pyrido[4,3-b]indoles containing rigid moieties | |
| JP6495285B2 (ja) | Ｔｎｆ活性のモジュレーターとしての縮合イミダゾール及びピラゾール誘導体 | |
| US7723347B2 (en) | Substituted phenylamino-pyrimidines | |
| US5594001A (en) | Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders | |
| JP2017516778A (ja) | 新規なピラゾロピリミジン誘導体およびｍａｌｔ１阻害剤としてのその使用 | |
| CA2566158A1 (en) | Kinase inhibitors as therapeutic agents | |
| HU205900B (en) | Process for producing alpha, alpha-disubstituted aromatic and heteroaromatic compounds and pharmaceutical compositions containing them | |
| NO884835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner. | |
| DE602004006869T2 (de) | 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit | |
| TW200533656A (en) | Therapeutic agents | |
| US5428035A (en) | 1-substituted azaoxindoles and pharmaceutical compositions | |
| IL109237A (en) | Polycyclic compounds and pharmaceutical compositions containing them | |
| JPH08501550A (ja) | ヒトの認識障害の治療に有用な３，３’−ジ置換−１，３−ジヒドロ−２Ｈ−ピロロ〔２，３−ｂ〕ヘテロ環式−２−オン | |
| US20200131180A1 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 | |
| US9193744B2 (en) | Heterocyclic nuclear hormone receptor modulators | |
| WO1993021185A1 (en) | Substituted nitrogen containing spiro compounds for use in treating cognitive deficits | |
| US5308851A (en) | Bispyridyl-containing heterocycles useful for treating cognitive disorders | |
| US20220041606A1 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 | |
| US5519132A (en) | Pyridine compounds | |
| WO1994009009A1 (en) | 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HP | Change in proprietorship | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |